bYoRNA

👥 13 employees💰 Last funded Apr 2025
Biotechnology Research🌐 byorna.bio
Website LinkedIn
ByoRNA uses eucaryotic cells as natural biofactories to make high-quality messenger RNA (mRNAs). Our bioproduction technology will help mass produce mRNA and enhance productivity at a fraction of the current cost. By perfecting an overlooked mRNA production method, we are helping build a more sustainable planet, save cancer patients and give their grand-children a future.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in bYoRNA?
bYoRNA has 1 investors on record on gritt.io.
When did bYoRNA last raise funding?
The most recent investment in bYoRNA recorded on gritt.io was in April 2025.
What industry is bYoRNA in?
bYoRNA operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.